Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
抗ＣＤ１９抗体及びガンマデルタＴ細胞を含む抗腫瘍併用療法
Document Type and Number:
Japanese Patent JP2022554324
Kind Code:
A
Abstract:
本開示は、白血病またはリンパ腫の治療に使用するための、抗ＣＤ１９抗体またはその抗体フラグメントとガンマデルタＴ細胞（γδＴ細胞）とを含む併用療法に関する。【選択図】なし

More Like This:
JP2023022186ANTI-DEATH RECEPTOR ANTIBODY AND METHOD OF USING SAME
WO/2023/172624IMMUNOSUPPRESSANTS IN COMBINATION WITH ANTI-IGM AGENTS AND RELATED DOSING
WO/2015/152417METHOD FOR PRODUCING ANTIBODY AGAINST TARGET ANTIGEN
Inventors:
Endel, Yang
Box hammer, liner
Pletcher, Dominic
Application Number:
JP2022525535A
Publication Date:
December 28, 2022
Filing Date:
October 30, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Morphosis Age
International Classes:
C07K16/28; A61K35/17; A61K39/395; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Yamato Kento
Norifumi Tomita



 
Previous Patent: Aqueous oxidizing composition containing amino acids

Next Patent: Rocket-assisted hydraulic support device